In a world of multiplying data and discourse, stakeholders across life sciences and healthcare are increasingly struggling to ...

The future of biopharma – key operational shifts to watch this year ...

Broadly defined as excess weight that puts an individual at higher risk for adverse health outcomes, obesity is associated ...

With healthcare systems around the world facing unprecedented challenges, now more than ever, there is a need for new, ...

Someone said I was ‘ambitious’ and followed up with ‘…they won’t be able to handle you – you’re too much for them’. I was in ...

Growing up in the eighties, I vividly remember the safe sex campaigns that warned of the dangers of HIV/AIDS. The tombstone ...

“Our 10 Year Health Plan will deliver the three big shifts our NHS needs to be fit for the future – from hospital to ...

Alligator Bioscience has announced updated results from its phase 2 OPTIMIZE-1 study, showing the survival benefits of ...

From a patient’s perspective, the outcome of using the NHS is predominantly some form of medication.

Microbiotica, a clinical-stage biopharma company, has presented new data on MB097 at the AACR IO meeting held in Los Angeles.

This edition of PharmaTimes is about the radical new look that pharma rocks these days – with it emerging dimensions, ...